April 24, 2024

Holland & Knight Health Dose: April 24, 2024

Sarah Starling Crossan | Abigail Hemenway
Holland & Knight Health Dose

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • Sen. Cassidy Questions FDA Oversight of Clinical Decision Support Software
  • Buchanan Asks MedPAC to Rethink Approach to Digital Health Tools
  • Surprise Billing Conversation Reignited
  • Last Week: House Committee on E&C Considers Medicare Physician Payment Reform
  • Lame Duck Health Package May Include PBM, 340B, Medicare PFS Reforms; Telehealth Flexibility Extensions
  • Retirements
  • CBO Releases Analysis of Medicare ACOs' Past Performance and Future Directions
  • CDER Announces New Center For Clinical Trial Innovation
  • 2024 CMS Health Equity Conference Live
  • FTC Finalizes Non-Compete Rule
  • ONC Releases Common Agreement 2.0, TEFCA Update

Read the full Health Dose »

Related Insights